GlaxoSmithKlein, the manufacturer of the antidepressant Paxil, has released on its company Web site reports of unpublished clinical tests of that drug in children and adolescents suffering from depression. Paxil is not approved for use in children but some doctors have prescribed it off label. SmithKline officials have denied that they selectively disclosed clinical trial findings. This is the first time that this data on Paxil have been made public and NPR's Joanne Silberner looks at whether it will give a different picture of the safety and efficacy of the drug.
Copyright 2004 NPR
